Cancer News and Research

Latest Cancer News and Research

Action on Hearing Loss funds new study to discover ways of preventing deafness caused by cancer drug

A widely used anti-cancer drug, cisplatin, can cause permanent and severe hearing loss, having a devastating impact on the quality of life for cancer survivors.

19 May 2016

Clinicians perform UK’s first MRI-guided focused ultrasound treatment for prostate cancer

INSIGHTEC congratulates the medical team at Imperial College Healthcare NHS Trust for performing the first MR-guided focused ultrasound treatment in the United Kingdom for prostate cancer.

19 May 2016

Flavopiridol drug could be effective strategy to impair brain cancer growth

Glioblastoma, the most common form of brain cancer is a deadly disease for which at present there is no cure. Now, researchers have published research results that show how repurposing the old drug flavopiridol could be an effective strategy to cut short sugar availability and impair cancer growth.

19 May 2016

Insilico Medicine collaborates with National Laboratory Astana to study age-related pathologies

Insilico Medicine announced an agreement with National Laboratory Astana, Nazarbayev University, one of the most rapidly growing universities in the world to collaboratively study aging and age-associated pathologies.

19 May 2016

Understanding antibody transport mechanisms in the brain

Diseases of the central nervous system (CNS), such as stroke, brain cancer, and Alzheimer's disease, are a serious threat affecting over 50 million Americans with an associated cost of over $750 billion per year, which is expected to grow significantly over the coming decades.

19 May 2016

Tecentriq drug gets FDA approval to treat urothelial carcinoma

The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer.

19 May 2016

Research sheds light on potential impact of HCV treatment in preventing virus transmission

An international team of researchers has shed light on the potential impact of new drugs for hepatitis C virus (HCV).

19 May 2016

Conventional repeated radiation treatments may offer no major benefit to brain tumor patients

A new study shows that repeated radiation therapy used to target tumors in the brain may not be as safe to healthy brain cells as previously assumed.

19 May 2016

Effective chemotherapeutic drug may induce permanent hearing loss in Cockayne syndrome individuals

The chemotherapy drug cisplatin can kill cancer, but it can also cause permanent hearing loss.

19 May 2016

Play-based procedural preparation helps reduce sedation use and costs tied to cranial radiation therapy

New research from St. Jude Children's Research Hospital shows support interventions by child life specialists decrease sedation use and costs associated with cranial radiation therapy.

19 May 2016

Neurotoxic effects of chemotherapy may impair cognitive function in young ALL patients

The neurotoxic effects of chemotherapeutic drugs on the developing brains of young patients with acute lymphoblastic leukemia (ALL) may impair their cognitive functioning by disrupting the formation of neural networks that connect brain regions and transfer information.

19 May 2016

ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

ProBioGen, a leading specialist for contract development and manufacturing of complex glycoproteins and corresponding technologies, today announced that Thermo Fisher Scientific has licensed its GlymaxX® technology for use in development of allergy diagnostics.

19 May 2016

EPIC Results Shed Light On First-Line Ponatinib Risk-Benefit Profile

The primary endpoint of major molecular response at 12 months for ponatinib versus imatinib in patients with newly diagnosed chronic phase-chronic myeloid leukaemia remains undetermined, report the EPIC trial investigators.

18 May 2016

UCLA Health's child life experts recognize need for hospital parents’ playroom

Everyone knows that, for kids, being in the hospital is no fun. That's why UCLA Health's child life specialists make sure hospitalized kids still get to be kids. They staff playrooms, orchestrate social events and bring movies and games to kids' bedsides.

18 May 2016

Wyss Institute partners with ReWalk to accelerate development of wearable, soft exosuits

The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities.

18 May 2016

Incorrect use of sunscreens could increase skin cancer risk

How well do you understand sunscreen? For many consumers, the answer is not so well. According to new research, many people are still puzzled by the wide range of SPF numbers on product labels, and some may not be using sunscreen properly, which could increase their skin cancer risk.

18 May 2016

Maintaining balance of P1 and P2 isoforms vital for reducing colon cancer, colitis risk

Inflammatory bowel disease (IBD), of which Crohn's disease and ulcerative colitis are the main types, is on the increase in the United States, affecting more than 1.6 million people and explaining perhaps the increase in advertisements offering treatments and cures.

18 May 2016

Inflammatory response prompted by secretion of cytokines causes acid reflux damage in GERD patients

The "acid" in "acid reflux" may not be the direct cause of damage to the esophagus as previously suspected, according to researchers at UT Southwestern Medical Center and Dallas VA Medical Center.

18 May 2016

Empowering mobile health: an interview with Dr Rich Khatib and Dan Vahdat

overview of Medopad and how you deliver patient information to mobile devices? Medopad is a mobile health technology company. We focus on developing software within the mobile health industry. Mobile health, from our perspective, is an industry that really was invented with the iPad.

18 May 2016

High levels of secretin hormone may play vital role in management of chronic liver diseases

High levels of a digestive hormone called secretin may play an important role in the management of certain chronic liver diseases, according to new research published in the journal Hepatology. These findings could result in new ways to treat cholestatic liver diseases, a condition that impairs the movement of bile, the fluid produced by the liver to digest fats.

18 May 2016

Cancer News and Research

Latest Cancer News and Research

Action on Hearing Loss funds new study to discover ways of preventing deafness caused by cancer drug

Clinicians perform UK’s first MRI-guided focused ultrasound treatment for prostate cancer

Flavopiridol drug could be effective strategy to impair brain cancer growth

Insilico Medicine collaborates with National Laboratory Astana to study age-related pathologies

Understanding antibody transport mechanisms in the brain

Tecentriq drug gets FDA approval to treat urothelial carcinoma

Research sheds light on potential impact of HCV treatment in preventing virus transmission

Conventional repeated radiation treatments may offer no major benefit to brain tumor patients

Effective chemotherapeutic drug may induce permanent hearing loss in Cockayne syndrome individuals

Play-based procedural preparation helps reduce sedation use and costs tied to cranial radiation therapy

Neurotoxic effects of chemotherapy may impair cognitive function in young ALL patients

ProBioGen will license GlymaxX® to Thermo Fisher Scientific for use in developing allergy diagnostics

EPIC Results Shed Light On First-Line Ponatinib Risk-Benefit Profile

UCLA Health's child life experts recognize need for hospital parents’ playroom

Wyss Institute partners with ReWalk to accelerate development of wearable, soft exosuits

Incorrect use of sunscreens could increase skin cancer risk

Maintaining balance of P1 and P2 isoforms vital for reducing colon cancer, colitis risk

Inflammatory response prompted by secretion of cytokines causes acid reflux damage in GERD patients

Empowering mobile health: an interview with Dr Rich Khatib and Dan Vahdat

High levels of secretin hormone may play vital role in management of chronic liver diseases

Understanding the DNA Damage Response in Innate Immunity eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Newsletters you may be interested in